Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stamp

Showing results (131-140 of 323) with videos related to

Pageof 33
Sort By:
Pharmacogenomics and Personalized Medicine|May 3, 2017
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approachesM C Cleophas, L A Joosten, L K Stamp, et al.
The Journal of Rheumatology|September 18, 2012
Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New ZealandRafi Raja, Peter T Chapman, John L O'Donnell, et al.
The Journal of Rheumatology|October 1, 2025
Do Monosodium Urate Crystals Reduce at Different Rates in Joints and Tendons During Urate-Lowering Therapy? A Dual-Energy Computed Tomography StudyWaimarama Mulqueen, Greg Gamble, Anthony Doyle, et al.
Internal Medicine Journal|October 9, 2009
Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritisD H N White, P T Chapman, J L O'Donnell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 5, 2020
Do Serum Urate-Associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK BiobankVicky Tai, Ravi K Narang, Greg Gamble, et al.
The Journal of Rheumatology|October 17, 2017
Rates of Joint Replacement Surgery in New Zealand, 1999-2015: A Comparison of Rheumatoid Arthritis and OsteoarthritisLisa K Stamp, Janine Haslett, Peter Chapman, et al.
Rheumatology (Oxford, England)|March 19, 2016
Clinical and genetic features of diuretic-associated gout: a case-control studySirisha Mitnala, Amanda Phipps-Green, Christopher Franklin, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 13, 2018
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving MethotrexateLisa K Stamp, John L OʼDonnell, Christopher Frampton, et al.
Arthritis Research & Therapy|July 7, 2018
Mediation analysis to understand genetic relationships between habitual coffee intake and goutJoseph Hutton, Tahzeeb Fatima, Tanya J Major, et al.
Rheumatology (Oxford, England)|September 9, 2023
The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapyCindy Cao, Greg Gamble, Anne Horne, et al.
Pageof 33

Showing results (131-140 of 323) with videos related to

Sort By:
Pageof 33
Pharmacogenomics and Personalized Medicine|May 3, 2017
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approachesM C Cleophas, L A Joosten, L K Stamp, et al.
The Journal of Rheumatology|September 18, 2012
Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association classification criteria for rheumatoid arthritis in an early arthritis cohort in New ZealandRafi Raja, Peter T Chapman, John L O'Donnell, et al.
The Journal of Rheumatology|October 1, 2025
Do Monosodium Urate Crystals Reduce at Different Rates in Joints and Tendons During Urate-Lowering Therapy? A Dual-Energy Computed Tomography StudyWaimarama Mulqueen, Greg Gamble, Anthony Doyle, et al.
Internal Medicine Journal|October 9, 2009
Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritisD H N White, P T Chapman, J L O'Donnell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 5, 2020
Do Serum Urate-Associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK BiobankVicky Tai, Ravi K Narang, Greg Gamble, et al.
The Journal of Rheumatology|October 17, 2017
Rates of Joint Replacement Surgery in New Zealand, 1999-2015: A Comparison of Rheumatoid Arthritis and OsteoarthritisLisa K Stamp, Janine Haslett, Peter Chapman, et al.
Rheumatology (Oxford, England)|March 19, 2016
Clinical and genetic features of diuretic-associated gout: a case-control studySirisha Mitnala, Amanda Phipps-Green, Christopher Franklin, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 13, 2018
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving MethotrexateLisa K Stamp, John L OʼDonnell, Christopher Frampton, et al.
Arthritis Research & Therapy|July 7, 2018
Mediation analysis to understand genetic relationships between habitual coffee intake and goutJoseph Hutton, Tahzeeb Fatima, Tanya J Major, et al.
Rheumatology (Oxford, England)|September 9, 2023
The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapyCindy Cao, Greg Gamble, Anne Horne, et al.
Pageof 33